The Achilles tendon is a common site of tendinopathy, causing pain, physical impairment, and disability1,2. Achilles tendinopathy is a common disorder arising from overuse, especially among athletes, but it is also prevalent in sedentary people and patients with rheumatologic and endocrine diseases3. Two distinct forms of Achilles tendinopathy can be diagnosed: midportion tendinopathy that affects the tendon 2-7 cm above its calcaneal insertion and insertional tendinopathy that involves the distal 2 cm of tendon proximal to the calcaneus4. Midportion Achilles tendinopathy is more frequently observed than insertional tendinopathy5,6, which generally occurs in rheumatologic7 and endocrine8 patients and in patients with Haglund deformity9.
Among diagnostic tests for the evaluation of the Achilles tendon, ultrasound is currently the most commonly adopted approach, but its use in clinical practice is typically limited to the quantitative measurements of tendon size (i.e., thickness and cross-sectional area) and qualitative assessment of the tendon structure10,11. Moreover, ultrasound poses problems such as inter/intra-operator variability and lack of standardization in acquisition protocols12. Therefore, many challenges arise when attempting to compare or analyze data acquired with different devices and with different acquisition protocols.
Ultrasound Tissue Characterization (UTC) is a new technique proposed to quantify the structural integrity of the tendon and overcome some limitations of the conventional ultrasound approach13. This method enables the quantification of the ultra-structural arrangement of the Achilles tendon by analyzing the three-dimensional stability of echo patterns (intensity and distribution) in contiguous transverse ultrasound images13. UTC provides a quantitative assessment of tendon integrity, expressed in terms of four different echo types. Echo type I reflects intact and aligned tendon bundles; echo type II corresponds to mildly disrupted and waving tendon bundles; echo type III results from mainly fibrillary tissue; and echo type IV represents areas composed mainly of amorphous matrix with a marked loss of fibrils, cellular elements, or fluid accumulation13,14.
Recent studies have shown that UTC has good to excellent reproducibility15,16,17,18 and can be used to monitor Achilles tendon changes in elite athletes after single exercise bouts19 and chronic exercise load20, in healthy21 and tendinopathic22 subjects after shockwave therapy, and in patients with midportion tendinopathy23,24. Moreover, UTC has been shown to detect and quantify mild tissue disorganisation, where conventional ultrasound fails to detect these changes. In fact, Docking et al.25 showed in patients with unilateral Achilles tendinopathy (midportion or insertional) that both tendons were structurally compromised, supporting the evidence for the bilateral nature of tendinopathy. We also recently found, in psoriatic arthritis patients with insertional tendinopathy, that UTC analysis was able to detect bilateral structural tendon alterations even when symptoms were unilateral26. Consistently, a recent systematic review27 concluded that UTC can also provide prognostic information in patients with Achilles tendinopathy: the decrease of echo type I and II percentages may precede and predict the occurrence of clinical symptoms. The purpose of the following protocol is to describe the procedure for assessing the Achilles tendon through the UTC approach.